MatchaDB

2026期刊论文可免费阅读

Matcha (Camellia sinensis): Bioactive Constituents, Pharmacological Activities, and Emerging Therapeutic Applications — A Comprehensive Review

Rohit Chavan*1, Rashmi Khairnar2, Pratiksha Aher2, Siddhi Avhad2

Journal of Pharmaceutical Sciences

在出版方阅读→

摘要

Matcha is not simply green tea in powdered form. It is the entire leaf — steamed, dried, deveined, and stone-ground from shade-grown Camellia sinensis (Theaceae) — consumed whole rather than steeped and discarded. That distinction turns out to matter more than most secondary literature acknowledges. Because the insoluble, fibre-bound fraction of the leaf never leaves the cup, matcha delivers a different catechin dose, and a different physical form of that dose, than a brewed infusion or a milligram-standardised green tea extract (GTE) capsule ever could. Most of what is written about matcha's pharmacology, however, was generated using one of those other two exposures. This review works through the peer-reviewed literature on matcha's botanical origin, cultivation, composition, and pharmacology with that distinction kept in view throughout, flagging section by section which claims rest on matcha itself and which are extrapolated from infusion or extract data. Shade cultivation for 20-35 days before harvest is the physiological event that makes matcha what it is: reduced light slows the enzymatic conversion of amino acids into catechins, so L-theanine accumulates instead of being consumed, while chlorophyll synthesis ramps up to compensate for the light lost. The result is the vivid colour, umami sweetness, and distinctive caffeine-to-theanine ratio that separate matcha from an ordinary green tea leaf — and, among the claims examined here, the ratio with the strongest direct trial support in matcha itself, rather than in a green tea proxy. Mechanistically, EGCG and the other catechins act on several fronts at once rather than through a single pathway: they scavenge reactive oxygen species directly and switch on the cell's own antioxidant machinery through Nrf2, they…

摘要已缩短。在来源处阅读完整摘要。

摘要文本来自PubMed、OpenAlex或Europe PMC,版权归作者和出版方所有。

研究类型

综述

对文献的叙述性或范围性综述。

根据标题、摘要和主题词自动分配。

主题

抹茶是这里的主要研究对象(出现在标题中)。

关键词与主题词

你的研究文件夹

引用这项研究

Rohit Chavan*1, Rashmi Khairnar2, Pratiksha Aher2, Siddhi Avhad2. (2026). Matcha (Camellia sinensis): Bioactive Constituents, Pharmacological Activities, and Emerging Therapeutic Applications — A Comprehensive Review. Journal of Pharmaceutical Sciences. https://doi.org/10.5281/zenodo.22071625

DOI:10.5281/zenodo.22071625

更多关于认知、情绪与压力

2020期刊论文可免费阅读

Health Benefits and Chemical Composition of Matcha Green Tea: A Review.

Kochman J, Jakubczyk K, Antoniewicz J等 — Molecules (Basel, Switzerland)

Japanese matcha is a type of powdered green tea, grown in a traditional way. Shading of the plants during the growth period enhances the processes of synthesis and accumulation of biologically active compounds, including theanine,…

综述认知、情绪与压力抗氧化物与多酚L-茶氨酸与咖啡因被引用376次
2018期刊论文可免费阅读

Stress-Reducing Function of Matcha Green Tea in Animal Experiments and Clinical Trials.

Unno K, Furushima D, Hamamoto S等 — Nutrients

Theanine, a major amino acid in green tea, exhibits a stress-reducing effect in mice and humans. Matcha, which is essentially theanine-rich powdered green tea, is abundant in caffeine. Caffeine has a strong antagonistic effect against…

随机对照试验认知、情绪与压力抗氧化物与多酚L-茶氨酸与咖啡因被引用98次
2017期刊论文可免费阅读

An intervention study on the effect of matcha tea, in drink and snack bar formats, on mood and cognitive performance.

Dietz C, Dekker M, Piqueras-Fiszman B — Food research international (Ottawa, Ont.)

Matcha tea is gaining popularity throughout the world in recent years and is frequently referred to as a mood-and-brain food. Previous research has demonstrated that three constituents present in matcha tea, l-theanine, epigallocatechin…

随机对照试验认知、情绪与压力抗氧化物与多酚L-茶氨酸与咖啡因被引用72次

浏览整个研究库→